Olmesartan-associated sprue-like enteropathy: A systematic review with emphasis on histopathology

Human Pathology

Volumn 50, Issue , 2016, Pages 127-134

  Burbure, Nina ^a   Lebwohl, Benjamin ^b   Arguelles Grande, Carolina ^b   Green, Peter H R ^b   Bhagat, Govind ^b   Lagana, Stephen ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

Angiotensin receptor blockers; Diarrhea; Enteropathy; Olmesartan; Sprue

Indexed keywords

OLMESARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ARTICLE; AUTOIMMUNE DISEASE; CASE STUDY; CELIAC DISEASE; CLINICAL OBSERVATION; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; SYSTEMATIC REVIEW; TROPICAL SPRUE; ANIMAL; BIOPSY; CHEMICALLY INDUCED; DIARRHEA; DRUG EFFECTS; INTESTINE; MALABSORPTION SYNDROMES; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; HUMANS; IMIDAZOLES; INTESTINES; MALABSORPTION SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TETRAZOLES;

EID: 84960962888     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.12.001     Document Type: Article

References (35)

1. A. Rubio-Tapia, M.L. Herman, J.F. Ludvigsson, and et al. Severe spruelike enteropathy associated with olmesartan Mayo Clin Proc 87 2012 732 738
2. S.M. Lagana, E.D. Braunstein, C. Arguelles-Grande, G. Bhagat, P.H. Green, and B. Lebwohl Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers J Clin Pathol 68 2015 29 32
3. M. Herman, A. Rubio-Tapia, E. Marietta, T. Wu, and J. Murray Severe enteropathy in a patient on valsartan [ACG abstract 1011] Am J Gastroenterol 108 Suppl. 1 2013 S302
4. J. Cyrany, T. Vasatko, J. Machac, M. Nova, J. Szanyi, and M. Kopacova Letter: telmisartan-associated enteropathy - is there any class effect? Aliment Pharmacol Ther 40 2014 569 570
5. G. Cammarota, G. Ianiro, S. Bibbo, and A. Gasbarrini Letter: telmisartan associated enteropathy - is there any class effect? Authors' reply Aliment Pharmacol Ther 40 2014 569 570
6. L. Marthey, G. Cadiot, P. Seksik, and et al. Olmesartan-associated enteropathy: results of a national survey Aliment Pharmacol Ther 40 2014 1103 1109
7. E.V. Marietta, A.M. Nadeau, A.K. Cartee, and et al. Immunopathogenesis of olmesartan-associated enteropathy Aliment Pharmacol Ther 42 2015 1303 1314
8. S. Scialom, G. Malamut, B. Meresse, and et al. Gastrointestinal disorder associate with olmesartan mimics autoimmune enteropathy PLoS One 10 2015 e0125024
9. A. Rubio-Tappia, N. Talley, S. Gurundu, T. Wu, and J. Murray Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue Clin Gastroenterol Hepatol 8 2010 344 349
10. M. DeGaetani, C.A. Tennyson, B. Lebwohl, and et al. Villous atrophy and negative celiac serology: A diagnostic and therapeutic dilemma Am J Gastroenterol 108 2013 647 653
11. K. Pallav, D.A. Leffler, S. Tariq, and et al. Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice Aliment Pharmacol Ther 35 2012 380 390
12. H. Theophile, X.R. David, G. Miremont-Salame, and F. Haramburu Five cases of sprue-like enteropathy in patients treated by olmesartan Dig Liver Dis 46 2014 465 469
13. N. Bhat, N. Anupama, A. Yelsangikar, and K. Vizhi Olmesartan-related sprue-like enteropathy Indian J Gastroenterol 33 2014 564 567
14. G. Ianiro, S. Bibbo, M. Montalto, R. Ricci, A. Gasbarrini, and G. Cammarota Systematic review: sprue-like enteropathy associated with olmesartan Aliment Pharmacol Ther 40 2014 16 23
15. J.A. Nielsen, A. Steephen, and M. Lewin Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug World J Gastroenterol 19 2013 6928 6930
16. P.P. Stanich, M. Yearsley, and M.M. Meyer Olmesartan-associated sprue-like enteropathy J Clin Gastroenterol 47 2013 894 895
17. S.E. Dreifuss, Y. Tomizawa, N.J. Farber, J.M. Davison, and A.E. Sohnen Spruelike enteropathy associated with olmesartan: An unusual case of severe diarrhea Case Rep Gastrointest Med 2013 2013 618071
18. A.S. Khan, S. Peter, and C.M. Wilcox Olmesartan-induced enteropathy resembling celiac disease Endoscopy 46 Suppl. 1 UCTN 2014 E97 E98
19. G. Fiorucci, E. Puxeddu, R. Colella, G. Paolo Reboldi, V. Villanacci, and G. Bassotti Severe spruelike enteropathy due to olmesartan Rev Esp Enferm Dig 106 2014 142 144
20. A. de Fonseka, A. Tuskey, and C. Moskaluk A case of olmesartan induced enteropathy Inflamm Bowel Dis 18 2012 S17
21. N. Heerasing, C. Hair, and S. Wallace Olmesartan-induced enteropathy Intern Med J 45 2015 117 118
22. V. Gaur, M. Albeldawi, and L. Weber Chronic diarrhea and weight loss Gastroenterology 146 2014 347 591
23. M. Abdelghany, L. Gonzalez III, J. Slater, and C. Begley Olmesartan associated sprue-like enteropathy and colon perforation Case Rep Gastrointest Med 2014 2014 494098
24. M. Basson, M. Mezzarobba, A. Weill, and et al. Severe intestinal malabsorption associated with olmesartan: A French nationwide observational cohort study [published online Aug 6 2015] Gut 2015 10.1136/gutjnl-2015-309690
25. R. Greywoode, E.D. Braunstein, C. Arguelles-Grande, P.H. Green, and B. Lebwohl Olmesartan, other antihypertensives, and chronic diarrhea among patients undergoing endoscopic procedures: A case-control study Mayo Clin Proc 89 2014 1239 1243
26. G.H. Talbot Small bowel histopathologic findings suggestive of celiac disease in an asymptomatic patient receiving olmesartan Mayo Clin Proc 87 2012 1231 1232 [author reply 1232]
27. S. Lam Azilsartan: A newly approved angiotensin II receptor blocker Cardiol Rev 19 2011 300 304
28. W.B. White, M.A. Weber, D. Sica, and et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension Hypertension 57 2011 413 420
29. J.A. Abrams, B. Diamond, H. Rotterdam, and P.H. Green Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy Dig Dis Sci 49 2004 546 550
30. J.K. Greenson The biopsy pathology of non-coeliac enteropathy Histopathology 66 2015 29 36
31. R. Masia, S. Peyton, G.Y. Lauwers, and I. Brown Gastrointestinal biopsy findings of autoimmune enteropathy: A review of 25 cases Am J Surg Pathol 38 2014 1319 1329
32. J.M. Tobin, B. Sinha, P. Ramani, A.R. Saleh, and M.S. Murphy Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: A blinded, controlled study J Pediatr Gastroenterol Nutr 32 2001 443 448
33. A. Sakuraba, Y. Iwao, K. Matsuoka, and et al. Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn's disease Biomed Res Int 2014 2014 610767
34. T. Nguyen, J.Y. Park, J.R. Scudiere, and E. Montgomery Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract Am J Surg Pathol 33 2009 1355 1363
35. N. Kamar, P. Faure, E. Dupuis, and et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients Transplant Int 17 2004 463 467